companydata.dkbiomee ApS: Financial statements 2020
CVR: 29829586
biomee ApS (CVR 29829586) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -461,055 and a net result of DKK -2,776,006 compared with DKK -2,353,230 the year before. Equity amounted to DKK -57,573,894.
- Gross Profit
- -461,055 kr.
- Profit/Loss
- -2,776,006 kr.
- Equity
- -57,573,894 kr.
- Total Assets
- 199,149 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -461 t. | -2.8 mio. | -57.6 mio. | - |
| 2019 | - | -273 t. | -2.4 mio. | -54.8 mio. | - |
| 2018 | - | -386 t. | -2.4 mio. | -52.4 mio. | 0 |
| 2017 | - | -7.8 mio. | -4.2 mio. | -50.1 mio. | - |
| 2016 | - | -33 mio. | -38.7 mio. | -45.8 mio. | - |
How creditworthy is biomee ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Biomee ApS has published its annual report for 2019. Gross profit came to DKK -272,730, and the net result was DKK -2,353,230.
About biomee ApS
biomee ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named DRUG DELIVERY SOLUTIONS ApS and TOXICELL ApS. The management consists of Trine Ahlgreen. The company is owned by MC2 Therapeutics A/S. In 2025, the company reported a gross profit of DKK 4,813,840 and a net result of DKK 6,548,744 compared with DKK 5,547,134 the year before. Equity amounted to DKK 23,772,837.